“the expertise has not kept pace with the demand, and that worries me,” said khatchadourian. she’s advocating for a national review in canada — one involving those working in the field, trans-identified individuals, parents and families and, as well, de-transitioners — to ensure practices are aligned with the best available evidence.
targownik also supports getting better data because, whether a populist or pragmatist, government leaders “are going to start asking for receipts,” she said.
“someone is going to come and say, ‘i know you believe this care works. if you believe so strongly in this, show me that it actually works. show me your outcomes. show me that the kids you’re transitioning are doing well a year later, two years, five years later. give me your best estimate of what the detransition rate in the modern cohort actually is, and the risk factors.”
there’s been a reluctance to ask those questions in the past when the practice was completely unhindered and support for gender care at its peak, she said.
now, more countries are questioning that blanket, blind “just affirm” approach.
khatchadourian favours aligning with sweden and finland’s approach, where puberty blockers and cross-sex hormones are reserved for children and teens with a history of gender dysphoria that started in early childhood and has persisted for many years.
for others, she recommends a more holistic approach, supporting youth as they’re going through identity development. she rejects accusations that she’s against gender affirming care. “gender care means i’m addressing the distress. of course that is a concern. ‘you have needs. i’m here to support your needs.’ but we haven’t asked the right question: what is the best way to address your needs?’
“we need to take a high level of risk approach, given the uncertainty of the evidence” and medication risks, she said. for her, the biggest stake is irreversible infertility.